Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2019 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Provides Update on GI Tumor Program for Investigational Cancer Drug PV-10

Metastatic neuroendocrine tumors: Monotherapy data presentations planned. Phase 2 combination therapy trial designs with different classes of checkpoint inhibitor drugs being developed.Metastatic...
March 21, 2019 08:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Provides Update on Metastatic Uveal Melanoma Clinical Development Program for Investigational Drug PV-10

KNOXVILLE, TN, March 21, 2019 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updates on the Company's metastatic uveal melanoma drug development program for its lead investigational...
January 08, 2017 16:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Announces Initiation of Three Pivotal Phase 3 Studies for Bempedoic Acid

Global Phase 3 Program Top-Line Results Expected Mid-2018 ANN ARBOR, Mich., Jan. 08, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on...